Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Tomczak

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Gut|June 5, 2024
Protective function of sclerosing cholangitis on IBDTanja Bedke, Friederike Stumme, Miriam Tomczak, et al.
Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Frontiers in Oncology|June 16, 2023
IL-22BP controls the progression of liver metastasis in colorectal cancerAnastasios D Giannou, Jan Kempski, Tao Zhang, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Gut|June 5, 2024
Protective function of sclerosing cholangitis on IBDTanja Bedke, Friederike Stumme, Miriam Tomczak, et al.
Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.
Frontiers in Oncology|June 16, 2023
IL-22BP controls the progression of liver metastasis in colorectal cancerAnastasios D Giannou, Jan Kempski, Tao Zhang, et al.
Pageof 1